10 Best Small-Cap Stocks to Buy Now According to Minerva Advisors

8. InfuSystem Holdings, Inc. (NYSE:INFU)

Number of Hedge Fund Holders: 7

Minerva Advisors held 846,851 shares of InfuSystem Holdings, Inc. (NYSE:INFU) valued at $7,274,451 by the end of Q1 2024. This investment made up 4.45% of Minerva Advisors’ portfolio, as per regulatory filings. InfuSystem Holdings, Inc. (NYSE:INFU)’s stock hasn’t done as well as the S&P 500, but the company has made big investments that should start paying off in 2024 and later. According to CEO Rich Dilorio, growth in 2024 is expected to be driven by InfuSystem Holdings, Inc. (NYSE:INFU)’s Biomed and Wound Care businesses, with chances for expansion and higher profits.

“In Biomed, this means completing the GE onboarding and then adding incremental projects to our growing national network of technicians. In Wound Care, this will mean continuing to place hardware into the channel and working with our joint venture partner Sanara to open that channel for distribution of the joint venture’s Advanced Wound Care products. Both of these opportunities will continue to scale and they will become significantly more accretive in 2024. Both have tremendous remaining potential, and both are expected to be material contributors to our top and bottom-line growth for years to come.”

Mr. Dilorio also said in their Q3 2023 conference call that 2023 has been focused on execution. He expects that in 2024, InfuSystem Holdings, Inc. (NYSE:INFU) will see significant improvements in operating returns:

“So, 2023 has been an execution year in terms of delivering new revenue opportunities and setting the stage for more revenue in future years. The next phase of execution will be the fine-tuning and the continuous process of identifying and implementing operating improvements that will improve and maintain our long-term operating margins. That will be the story for the rest of this year (2023) and into next year (2024).”